TRIM65 has also been shown to promote colorectal cancer metastasis through targeted ubiquitination and degradation of ARHGAP35 protein [15] and activates ERK1/2/C-myc signaling by targeting ubiquitination to degrade DUSP6 protein, thereby promoting the invasion of endometrial stromal cells [16]. This evidence concerns the gene MYC and colorectal cancer.